(Reuters) - Lupin Ltd, India's second-largest drugmaker by revenue, posted a 41.5 percent fall in second-quarter profit on Wednesday, hurt by higher expenses.
Net profit was 2.66 billion rupees ($36.00 million) in the quarter ended Sept. 30, compared with a profit of 4.55 billion rupees a year earlier, Lupin said.
Analysts on average had expected a profit of 2.73 billion rupees, according to Refintiv data.
Income from operations rose marginally to 38.91 billion rupees.
($1 = 73.8850 Indian rupees)
(Reporting by Tanvi Mehta in Bengaluru; Editing by Amrutha Gayathri)
Disclaimer: No Business Standard Journalist was involved in creation of this content
